ArticleESMO real world data and digital oncology2025
Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohort.
G George et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.